Melior Is Recognized as CRO of the Year by Life Sciences Review

Life Sciences Review annually selects 10 preeminent CROs and has chosen Melior Discovery as the top CRO in 2023

The editors recognized Melior’s unique capabilities in the pre-clinical in vivo pharmacology space with its theraTRACE offering, its breadth of model offerings, and boutique client interaction experience

See more here